MEMBRANOUS NEPHROPATHY
Clinical trials for MEMBRANOUS NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new MEMBRANOUS NEPHROPATHY trials appear
Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests 'Universal' cell injection for tough kidney diseases
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called GT719 in adults with several types of immune-mediated kidney diseases that have not responded well to standard treatments. The main goals are to find a safe dose and see how well the body tolerates the treatment, while a…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
AI steps in to fix failing kidney treatments
Disease control Recruiting nowThis study aims to improve treatment for membranous nephropathy, a serious autoimmune kidney disease. It will test if using a machine learning (AI) algorithm to predict which patients have too little medication in their system can help doctors give personalized, extra doses of ri…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo targets immune system in serious kidney disease
Disease control Recruiting nowThis study is testing a new drug, HLX79, given alongside an existing drug called rituximab, to see if it is safe and can help control active kidney disease caused by membranous nephropathy or lupus. It will involve about 24 adults who have not responded well to standard care. The…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Double attack on rogue immune cells could protect kidneys
Disease control Recruiting nowThis study is testing if a combination of two immune-suppressing drugs works better than one to control primary membranous nephropathy, a serious autoimmune disease that damages the kidneys. It will enroll 58 adults to see if adding belimumab to rituximab leads to a more lasting …
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New system aims to connect kidney patients with right clinical trials
Knowledge-focused Recruiting nowThis study tests a new system that helps match kidney disease patients with clinical trials that might be right for them. It works by analyzing patient information to find trials targeting their specific type of kidney condition. The study also measures how well patients understa…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Doctors follow 500 kidney patients to unlock secrets of treatment success
Knowledge-focused Recruiting nowThis study aims to understand how well patients with a specific kidney disease called primary membranous nephropathy do when treated with antibody medications like rituximab in real-world settings. Researchers will follow 500 adult patients who have this disease with significant …
Matched conditions: MEMBRANOUS NEPHROPATHY
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists probe why kidney treatments fail for some
Knowledge-focused Recruiting nowThis study aims to understand why some patients with a kidney disease called membranous nephropathy get better with a specific treatment while others do not. Researchers will closely examine the immune cells of 86 patients and healthy volunteers before and after treatment. The go…
Matched conditions: MEMBRANOUS NEPHROPATHY
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Patients share their stories to shape future kidney disease treatments
Knowledge-focused Recruiting nowThis study aims to understand how swelling affects the daily lives of children and adults with Nephrotic Syndrome, a serious kidney disease. Researchers will conduct interviews with patients and parents to learn about their experiences. The information gathered will be used to cr…
Matched conditions: MEMBRANOUS NEPHROPATHY
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC